Penile rehabilitation protocol after robot‐assisted radical prostatectomy: assessment of compliance with phosphodiesterase type 5 inhibitor therapy and effect on early potency
Authors:
- 14 January 2010
- journal article
- Published by Wiley in BJU International
- Vol. 105 (3) , 382-388
Abstract
Study Type – Therapy (case series) Level of Evidence 4 OBJECTIVE: To evaluate factors that affect compliance in men who enrol in a phosphodiesterase type 5 inhibitor (PDE5I) protocol after nerve‐sparing robot‐assisted prostatectomy (RAP), and report on short‐term outcomes, as PDE5Is may help restore erectile function after RAP and patient adherence to the regimen is a factor that potentially can affect outcome. PATIENT AND METHODS: We prospectively followed 77 men who had nerve‐sparing RAP and enrolled in a postoperative penile rehabilitation protocol. The men received either sildenafil citrate or tadalafil three times weekly. The minimum follow‐up was 8 weeks. Potency was defined as erection adequate for penetration and complete intercourse. Compliance was defined as men adhering to the regimen for ≥2 months. RESULTS: The mean age of the cohort was 57.8 years and the median follow‐up was 8 months. In all, 32% of the men discontinued the therapy <2 months after RAP and were deemed noncompliant with an additional 39% discontinuing therapy by 6 months, with the high cost of medication being the primary reason (65%). Long‐term compliance and preoperative erectile dysfunction were independent predictors of potency return after adjusting for age and nerve sparing. CONCLUSIONS: The high cost of medication remains a significant barrier to maintaining therapy. Noncompliance to PDE5I therapy in a tertiary care centre was much higher than reported in clinical trial settings. With longer‐term follow‐up, we need to further define the factors that improve overall recovery of sexual function after RAP.Keywords
This publication has 34 references indexed in Scilit:
- Single Institution 2-Year Patient Reported Validated Sexual Function Outcomes After Nerve Sparing Robot Assisted Radical ProstatectomyJournal of Urology, 2009
- Acceptance of and Discontinuation Rate from Erectile Dysfunction Oral Treatment in Patients following Bilateral Nerve-Sparing Radical ProstatectomyEuropean Urology, 2008
- Return of Nocturnal Erections and Erectile Function after Bilateral Nerve-sparing Radical Prostatectomy in Men Treated Nightly with Sildenafil Citrate: Subanalysis of a Longitudinal Randomized Double-blind Placebo-controlled TrialThe Journal of Sexual Medicine, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Age Difference Between Patient and Partner is a Predictive Factor of Potency Rate Following Radical ProstatectomyJournal of Urology, 2006
- Sexual Function Before and After Radical Retropubic Prostatectomy: A Systematic Review of Prognostic Indicators for a Successful OutcomeEuropean Urology, 2006
- Prediction of Postoperative Sexual Function After Nerve Sparing Radical Retropubic ProstatectomyJournal of Urology, 2006
- Sildenafil Failures May Be Due to Inadequate Patient Instructions and Follow-Up: A Study on 100 Non-RespondersEuropean Urology, 2005
- Vattikuti Institute Prostatectomy: TechniqueJournal of Urology, 2003
- MECHANISM OF INHIBITION OF ENDOTHELIN-1–STIMULATED PROTEOGLYCAN AND COLLAGEN SYNTHESIS IN RAT ARTICULAR CHONDROCYTESCytokine, 2002